Center for Bioethics and Health Law

Dealing with Drugs: Ethical, Legal, and Policy Issues

From the Opioid Epidemic to Budget-Busting Blockbuster Drugs

Annual Medical Ethics Conference – 2018

Friday, March 23, 2018 | 8:30 am – 4:30 pm
Scaife Hall – 11th Floor Conference Center
University of Pittsburgh


Pitt's Center for Bioethics and Health Law is hosting a conference to explore the varied roles drugs play in the health of individuals and in their communities. Speakers from the University of Pittsburgh and other institutions will address ethical, legal, and policy issues associated with the roles of drugs and drug users.  CP3 Director Dr. Walid Gellad is presenting a talk on "Medication Adherence in the Era of Expensive Oral Cancer Therapy." CP3 Co-Director Dr. Julie Donohue will be speaking on "Policy Challenges in Expanding Access to Opioid Addiction Treatment."

For more information and to register, visit the conference page.






Past Events

Medication Adherence Conference, 2015

In June 2015, Dr. Gellad chaired a conference on Medication Adherence entitled "The Science of Medication Adherence. Moving Adherence Measurement Forward". The conference was a unique opportunity to bring together individuals from academia, industry, and government from across disciplines to focus on the science of how adherence is and should be measured.

This inaugural conference focused on two issues central to adherence measurement:

  • Measuring adherence in patients taking multiple medications for multiple chronic conditions,

  • Measuring adherence longitudinally

Additional key topics related to medication adherence were also discussed at the conference.

  • Identifying and synthesizing the gaps in current measurement methods;

  • Measuring adherence within a delivery system, rather than in specific patients;

  • Implications of setting adherence thresholds as clinical and policy targets (i.e. is 80% PDC right for everyone?);

  • Identifying how technology/electronic medical records can change the measurement of adherence;

  • Implications of adherence measurement in clinical trial design; and

  • Implementation of adherence measures in real-world health systems and practice